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SOX10 is abnormally expressed in aganglionic
bowel of Hirschsprung’s disease infants
M H Sham, V C H Lui, M Fu, B Chen, P K H Tam
Abstract
Background—The primary pathology of
Hirschsprung’s disease (HD) is a congeni-
tal absence of ganglion cells in the caudal
most gut. The spastic aganglionic bowel is
often innervated by a network of hypertro-
phied nerve fibres. Recently, mutations of
SOX10 have been identified in patients
with HD but only in those with
Waardenburg-Shah syndrome.
Aims—To understand the molecular basis
for the pathogenesis of HD we intended to
determine the specific cell lineages in the
enteric nervous system which normally
express SOX10 but are aVected in disease
conditions.
Methods—We studied colon biopsies from
10 non-syndromic HD patients, aged
three months to four years, and 10 age
matched patients without HD as normal
controls. The absence of mutation in the
SOX10 gene of HD patients was confirmed
by DNA sequencing. Expression and cel-
lular distribution of SOX10 in bowel
segments of normal and HD infants were
examined by reverse transcription-
polymerase chain reaction and in situ
hybridisation.
Results—We found that in normal infants
and normoganglionic bowel segments of
HD patients, SOX10was expressed in both
neurones and glia of the enteric plexuses
and in the nerves among the musculature
in normal colon. In the aganglionic bowel
segments of patients, SOX10 expression
was consistently lower and was found to be
associated with the hypertrophic nerve
trunks in the muscle and extrinsic nerves
in the serosa.
Conclusion—We conclude that SOX10 is
normally required postnatally in the func-
tional maintenance of the entire enteric
nervous system, including neurones and
glia. In non-syndromic HD patients who
do not have the SOX10 mutation, the
SOX10 gene expressed in the sacral region
may be involved in the pathogenesis of the
abnormal nerve trunks through interac-
tion with other factors.
(Gut 2001;49:220–226)
Keywords: SOX10; polymorphism; enteric nervous
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The enteric nervous system (ENS) is a unique
division of the nervous system which controls
important gut functions, including motility,
and can function independently of the central
nervous system. It consists of a large number of
neurones and specialised enteric glia aggre-
gated in interconnecting ganglia in plexuses
within the gut wall. The ENS arises from neu-
ral crest cells through a complex process of
migration, proliferation, growth, and diVeren-
tiation. Interference with normal development
of the ENS results in neurocristopathies, such
as Hirschsprung’s disease (HD) which occurs
in 1:5000 births. The primary pathology of HD
is a congenital absence of ganglion cells in the
distal gut which leads to intestinal obstruction,
resulting in considerable morbidity and mor-
tality.
HD is a polygenic disease. About half of
familial and 17–20% of sporadic cases are
associated with the RET receptor tyrosine
kinase gene,1–6 and fewer with mutations in the
endothelin 3 (EDN3),7 8 endothelin B receptor
(EDNRB),9–13 glial derived neurotrophic factor
(GDNF),5 neuturin,14 and unidentified modi-
fier15 genes. Recently, mutations in the SOX10
gene have been described in HD patients but
only in those who also show pigmentary defects
and/or deafness (Waardenburg-Shah
syndrome).16–19 The SOX10 gene encodes a
HMG domain containing Sry related tran-
scription factor.20 The presence of SOX10
mutations in Waardenburg-Hirschsprung pa-
tients suggests that the SOX10 gene could be
involved in regulatory and signalling pathways
for the early development of the neural crest
cell lineages which diVerentiate into melano-
cytes and enteric ganglia. The involvement of
Sox10 in the development of enteric neurones
has also been demonstrated in the Dom (Domi-
nant megacolon) mouse model of HD. It was
shown that a single base insertion in the mouse
Sox10 gene was responsible for the megacolon
phenotype of the Dom mutant.21 22
The ENS mainly originates from the vagal
neural crest during early development but
there is also a small contribution of enteric
ganglia from the sacral neural crest in the distal
gut.23–27 In the aganglionic colon of HD, the
sacral neural crest is unable to compensate for
the loss of vagal neural crest derived enteric
ganglia.28–30 Moreover, the spastic aganglionic
bowel is often innervated by a network of
hypertrophied nerve fibres which are thought
to be extrinsic preganglionic parasympathetic
nerve fibres originating from the sacral para-
sympathetic region.31 Previous studies on the
genes involved in HD have focused on their
roles in the vagal neural crest derived lineages.
In fact many of the genes known to be involved
Abbreviations used in this paper: Dom, dominant
megacolon; EDN3, endothelin 3; EDNRB, endothelin
B receptor; ENS, enteric nervous system; HD,
Hirschsprung’s disease; RT-PCR, reverse
transcription-polymerase chain reaction.
Gut 2001;49:220–226220
Division of Paediatric
Surgery, Department
of Surgery, University
of Hong Kong,
Pokfulam, Hong Kong,
China
V C H Lui
M Fu
B Chen
P K H Tam
Department of
Biochemistry,
University of Hong
Kong, Pokfulam, Hong
Kong, China
M H Sham
Correspondence to:
Professor P K H Tam,
Division of Paediatric
Surgery, Department of
Surgery, University of Hong
Kong Medical Centre,
Queen Mary Hospital,
Pokfulam, Hong Kong SAR,
China.
paultam@hkucc.hku.hk
Accepted for publication
29 January 2001
www.gutjnl.com
 on 24 January 2007 gut.bmj.comDownloaded from 
in HD are expressed in both the vagal and sac-
ral neural crest regions during human embry-
onic development.32 33 Therefore, it is likely
that the genes which aVect proliferation,
migration, and diVerentiation of vagal neural
crest and cause the development of HD will
also have similar eVects on the sacral neural
crest.
Previous studies on the expression patterns
of SOX10 have mainly focussed on fetal
stage19 32: the cellular distribution of SOX10 in
postnatal tissues is not known. In order to
understand the molecular basis underlying the
pathology of HD, we examined the cellular
expression patterns of SOX10 in the colon of
normal infants and non-syndromic HD pa-
tients. Our results on the cellular distribution
of SOX10 suggests that this gene is expressed in
cells that are of vagal as well as sacral neural
crest origin and SOX10 may have an important
role in the pathogenesis of HD.
Methods
TISSUES FROM PATIENTS
Colon tissues were obtained from 10 patients
with HD during pull through operation. Age
ranged from three months to four years. There
were eight boys and two girls. Nine patients
had classical short segment aganglionosis with
rectal or rectosigmoid involvement and one
patient had aganglionosis extending to the
splenic flexure. There was no family history
and no associated major anomalies or syn-
dromes. After mobilisation of the hypertro-
phied and spastic colon, colon tissue samples
were taken from the normal segment, transi-
tional segment (hypoganglionic), and spastic
segment (aganglionic). Tissues from normal
controls were obtained from colon biopsies at
gastrointestinal operation for age matched
patients without HD (n=10). These infants
and children had anorectal anomalies (anorec-
tal atresia n=5; anal atresia n=2; anterior
ectopic anus n=1) and necrotising enterocolitis
of the distal gut (n=2) and underwent colos-
tomy or closure of colostomy at unaVected
parts of the colon.
Tissue samples were subdivided for fixation
in 4% paraformaldehyde solution for histologi-
cal sectioning, snap freezing in liquid nitrogen,
and storage at −80°C for molecular analysis.
MUTATION DETECTION
DNA was extracted from peripheral blood
samples collected from patients using a
QiaAmp blood kit (Qiagen, Valencia, Califor-
nia, USA). Six sets of primers were used to
amplify SOX10 gene fragments covering exons
2 to 5 and intron-exon junctions by polymerase
chain reaction (PCR). The PCR products were
purified and the DNA sequences determined
by an automated sequencer (ABI Prism 310)
after cycle sequencing reactions (dRhodamine
kit). All sequences were determined from both
forward and reverse orientations. Mutations
were confirmed using duplicate PCR tem-
plates.
RNA EXTRACTION AND REVERSE
TRANSCRIPTION-POLYMERASE CHAIN REACTION
(RT-PCR)
RNA samples were extracted from frozen
tissues by the acid guanidinium-phenol-
chloroform extraction method.34 Reverse tran-
scription (RT) was performed using the Super-
Script kit (Life Technologies, Rockville,
Maryland, USA) according to the manufactur-
er’s instructions. For PCR reaction, the PCR
reagent system kit from Life Technologies was
used according to the manufacturer’s instruc-
tions. The sequences of the SOX10 primers
were 5'-ATA CGA CAC TGT CCC GGC
CCT AAA-3' and 5'-TTC TCC TCT GTC
CAG CCT GTT CTC-3'. As a control â-actin
primers were used and their sequences were
5'-ACT CTT CCA GCC TTC CTT CC-3'
and 5'-CGT CAT ACT CCT GCT TGC
TG-3'. The SOX10 and â-actin cDNAs were
amplified in separate PCR reactions. Samples
that lacked RT were also amplified to control
for the presence of any contaminating genomic
DNA.
IN SITU HYBRIDISATION
To prepare the SOX10 probe, a 570 bp
fragment corresponding to the 3'-untranslated
region was amplified using another set of prim-
ers (5'-TGC CCT GTT CCT TGC CCA
CCT C-3' and 5'-GGC CTC TGT GCC AAC
TCC TTC C-3') by RT-PCR using normal
human infant colon RNA. The PCR product
was cloned into pBluescript KSII+ and the
nucleotide sequence of the cloned product was
confirmed by sequencing. Single stranded
[35S]-UTP labelled sense and antisense ribo-
probes were generated from a linearised
SOX10 clone. Synthesis of riboprobes, hybridi-
sation, autoradiography, and histological stain-
ing were carried out as described previously.35
The isotope 35S is weak in decay energy and
travels for only a short distance. We and
others35 have found in situ hybridisation using
35S labelled riboprobe to give very good resolu-
tion for localisation of gene transcripts, espe-
cially when used in combination with immuno-
histochemistry for adjacent sections (see
below). Slides were exposed in the dark at 4°C
for 21 days. Photomicrographs were taken on
an Axioplan 2 microscope (Carl Zeiss) fitted
with a Sony digital camera under dark field or
bright field illumination.
IMMUNOHISTOCHEMISTRY
ParaYn sections were treated with 3% H2O2 for
10 minutes to block endogenous peroxidase
activity and with 10 mM citrate buVer (pH 6.0)
at 85°C for 10 minutes for antigen retrieval.
Sections were incubated with primary antibody
(for S100: clone 4C4.9, NeoMarkers, Fre-
mont, California, USA 1:100 dilution; for
RET: anti-RET R5, Nagoya University,
Nagoya, Japan 1:100 dilution) in phosphate
buVered saline containing 0.1% Tween 20 and
10% horse serum at 4°C for 16 hours, and then
with horseradish peroxidase conjugated sec-
ondary antibody at 37°C for one hour.
Immunoreactivity was visualised using
strepABComplex/HRP kit (Dako, Carpinteria,
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Figure 1 Expression of SOX10 in both neurones and glia of enteric plexuses in the colon of normal infants. (A) Dark
field illumination of a cross section of normal colon showing strong in situ hybridisation signals in myenteric plexuses and in
the nerves in the longitudinal and circular muscular layers. (B) Bright field illumination of an adjacent section showing
S100 immunoreactivity in the SOX10 positive cells. (C) Dark field illumination and (F, I) bright field illumination of a
myenteric plexus hybridised in situ with a SOX10 probe. (D,G, J) Immunohistochemistry of an adjacent section with
S100 antibody showing that the glial cells present in the plexus are stained. (E,H,K) Immunohistochemistry of another
adjacent section with RET antibody showing that the neurones and nerves in the plexus are stained. For comparison, in I,
J, and K, the same glial cells are marked with arrows and the neurones are circled by broken lines. Both glial cells
immunoreactive for S100 and neurones immunoreactive for RET had positive SOX10 hybridisation signals. Original
magnification: (A, B) ×100; (C,D, E) ×400; (F,G,H) ×500; (I, J, K) ×1000. Sm, submucosa; cm, circular muscle; lm,
longitudinal muscle.
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California, USA) and DAB (Sigma, St Louis,
Missouri, USA). Sections were counterstained
with haematoxylin, dehydrated, cleared in
xylene, and mounted in DPX mountant
(BDH, Poole, UK).
Results
We examined the presence and numbers of
ganglionic plexuses in colon biopsies of HD
patients. For each patient the tissue sample was
divided into three segments designated agan-
glionic (spastic), hypoganglionic (transitional),
and normoganglionic segments. For the agan-
glionic segments, we confirmed the absence of
any ganglionic cells from the histological
sections. We counted the number of ganglionic
plexuses in the sections of hypoganglionic and
normoganglionic colon segments and found
fewer ganglia in the hypoganglionic than in
normal segments. The diVerence however did
not reach statistical significance. We performed
sequence analysis on the SOX10 gene of HD
patients. A polymorphic A→G change at
nucleotide position 1876 (in exon 5, 475
nucleotides downstream of the stop codon)
was detected in two patients. One of these two
patients also had an additional silent mutation
of CAC→CAT at codon 309. None of these
nucleotide changes aVect the SOX10 coding
region and the other patients had normal
SOX10 sequences.
EXPRESSION OF SOX10 IN THE COLON OF NORMAL
INFANTS
It has previously been demonstrated by north-
ern hybridisation that SOX10 is expressed in
human colon. However, which cell types
express SOX10 transcript is not yet known. We
first examined bowel specimens from normal
infants by in situ hybridisation. As shown in fig
1A, SOX10 mRNA was restricted to cells
within the ganglionic plexuses. Clear punctate
spots of SOX10 positive signals were also found
in the nerve fibres of the muscular layers of the
gut wall. By immunohistochemistry using an
antibody against the glial cell marker S100 on
adjacent sections, we found that the SOX10
hybridisation signals largely overlapped with
cells which were immunoreactive for the S100
antibody (fig 1B).
To further examine the cellular distribution
of SOX10 in the neuronal plexuses of normal
colon, we used anti-RET antibody which
reacted with neuronal membrane bound RET
receptor as a marker for enteric neurones and
compared expression patterns of SOX10,
S100, and RET. As shown in fig 1 (C–K), in the
myenteric plexus a few RET immunoreactive
cells were identified (fig 1E, H, K) and the
plexus contained a number of smaller S100
positive cells which were the enteric glia (fig
1D, G, J). In the myenteric plexuses examined,
SOX10 hybridisation signals were found in all
cells in the ganglia, including neurones and glia
(fig 1C, F, I). Therefore, in human colon,
SOX10 expression is restricted to the ENS and
is present in both neuronal and glial cells.
EXPRESSION OF SOX10 IN HD PATIENTS
We initially studied expression of SOX10 in
HD patients by RT-PCR. As shown in fig 2, a
DNA band of about 250 bp corresponding to a
SOX10 fragment of expected size was detected
in normal control colon tissues, and also in all
three colon segment samples (normogangli-
onic, hypoganglionic, and aganglionic) ob-
tained from HD patients. The control â-actin
band of about 300 bp was amplified from all
cDNA samples. No DNA was amplified from
the control samples which lacked RT, indicat-
ing that the amplified SOX10 and â-actin frag-
ments were derived from RNA. For all patients
studied, we were able to detect expression of
the SOX10 gene although at a lower level in the
aganglionic segments (data not shown).
We performed semiquantitative PCR experi-
ments using expression of the â-actin gene as a
reference and we found that expression of
SOX10 in the aganglionic segments was
consistently lower than in hypoganglionic and
normal segments (data not shown). The
relative band intensity of SOX10 in 10 normal
control samples was similar to that of the
hypoganglionic and normal segments of pa-
tients (data not shown).
CELLULAR DISTRIBUTION OF SOX10 IN THE COLON
OF HD PATIENTS
We further examined expression patterns of
SOX10 in the colon of patients with HD. In the
normoganglionic colon segments of HD pa-
tients, SOX10 mRNA was restricted to cells
within the ganglionic plexuses (fig 3A, B).
Clear punctate spots of SOX10 positive signals
could also be found in the nerve fibres of the
muscular layers of the gut wall (fig 3B). Similar
results were obtained from hypoganglionic
colon segments (data not shown). The pattern
of SOX10 expression is similar to that in
normal infants (fig 1). Interestingly, in the
aganglionic segment of HD patients, despite
the absence of functional neuronal cells, weak
SOX10 hybridisation signals could be detected
in clumps of cells which resembled ganglia but
were in fact aggregates consisting of hypertro-
phied nerve trunks and glia (fig 3C, D).
Detailed examination showed that SOX10
Figure 2 Expression of SOX10 in the aganglionic (A),
hypoganglionic (H), and normoganglionic (N) colon
segments of a Hirschsprung’s disease (HD) patient
examined by reverse transcription-polymerase chain
reaction (RT-PCR) in the presence (+) and absence (−) of
reverse transcriptase. Expression of SOX10 in normal
control colon tissue (C) is also shown. The expected SOX10
fragment of about 250 bp was amplified from normal
control and HD patient samples. As a control the â-actin
band of about 300 bp was also amplified from all samples.
No DNA fragment could be amplified from cDNA samples
that lacked reverse transcriptase (−) indicating that the
amplified bands were derived from mRNA.
A H N C
SOX10
b -actin
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expression could also be detected in the extrin-
sic nerves in the serosa (fig 3E–G) in addition
to the hypertrophic nerves in the musculature
(fig3H–L)oftheaganglionicsegment.Immuno-
histochemistry of adjacent sections using anti-
bodies against S100 (fig 3E, I) and RET (fig 3J)
Figure 3 Expression of SOX10 in the normoganglionic (A, B) and aganglionic (C–L) colon segments of a
Hirschsprung’s disease patient examined by in situ hybridisation. SOX10 is expressed in myenteric plexuses (arrowhead)
and nerves in the circular and longitudinal muscles in the normoganglionic colon (A, bright field; B, dark field). In the
aganglionic colon, SOX10 is expressed in the hypertrophic nerve trunks and in nerves in the musculature (C,K, bright
field; D, L, dark field). Immunohistochemistry on adjacent sections using S100 (H, I) and RET (J) antibodies confirms
that the hypertrophic nerves contain nerve fibres and glial cells but no neurones. The SOX10 positive signals are found in
the glia and nerve bundles. In addition, SOX10 is also weakly expressed in extrinsic nerves (F, bright field; G, dark field;
arrowhead, blood vessel) in the serosa. Immunohistochemistry on an adjacent section shows that the extrinsic nerve is
immunoreactive for S100 antibody (E).Original magnification: (A-D) ×100; (E) ×200; (F,G, I–L) ×500; (H) ×100.
Sm, submucosa; cm, circular muscle; lm, longitudinal muscle; s, serosa.
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further supported the fact that the SOX10
hybridisation signals overlapped with the glial
cells and nerve bundles. Our in situ hybridisa-
tion results confirmed our PCR analysis above
in that SOX10 was indeed expressed in
aganglionic bowel but at a reduced level
compared with normal bowel segments.
Discussion
In developing mouse embryos, Sox10 is ex-
pressed in migrating neural crest and periph-
eral nervous system derivatives. At 12.5 dpc
Sox10 can be detected in the gut in locations
consistent with myenteric ganglia.21 22 36 At later
stages of development Sox10 is expressed in the
peripheral nervous system in Schwann cells; in
the central nervous system Sox10 transcripts
are first detected in glial precursors and later in
oligodendrocytes of the adult brain. This has
led to the suggestion that in later development,
Sox10 is important for defining and maintain-
ing the identity of glial cells.36 In situ hybridisa-
tion has also been performed using early
human embryos and similar expression pat-
terns were found in humans as in mice.19 32
However, specific expression of SOX10 in the
ENS of postnatal tissue had not been examined
previously.
We have studied expression of SOX10 in the
colon of normal infants and HD patients. We
showed that SOX10 was expressed in the colon
tissues of normal control individuals, suggest-
ing that SOX10 function is required not only
during early fetal stages but also in the mature
ENS of the gut after embryonic development.
The expression pattern of SOX10 in the bowel
segment is remarkably similar to that of neuro-
nal nitric oxide synthase and nerve growth fac-
tor receptor.37 38 Clear SOX10 expression was
detected in the myenteric and submucosal
plexuses, and around the nerve fibres in the
longitudinal and circular muscular layers in
normal bowel segments. Using glial and neuro-
nal markers, S-100 and RET respectively on
adjacent sections, we found that SOX10
positive signals overlapped with both glial and
neuronal cells. Therefore, our results showed
that both glial and neuronal cells in the ENS
expressed SOX10. While in the peripheral and
central nervous systems SOX10 may be
required only in glial cells,36 39 in the infant
ENS we have shown that SOX10 expression
was not restricted to glia but was also found in
neurones. Our results on the cellular distribu-
tion of SOX10 mRNA in enteric ganglia
plexuses and nerves strongly support the fact
that the SOX10 gene is involved in the normal
development and functioning of the entire
ENS.
The pathological characteristics of HD are
the absence of ganglion cells in the myenteric
and submucosal plexuses, and the presence of
hypertrophied nerve trunks in the distal colon.
The abnormal nerve bundles consist of cholin-
ergic nerve fibres38 40 41; they are immunoreac-
tive for an antibody against nerve growth factor
receptor38 and they are believed to be extrinsic
parasympathetic nerve fibres of sacral ori-
gin.31 42 It is clear that the major cellular defect
in HD is abnormal development of vagal neu-
ral crest derived intrinsic ganglia leading to a
deficiency of ganglion cells to populate the dis-
tal colon. Normally, sacral neural crest cells
also contribute to intrinsic ganglia in the distal
colon and it is not clear why the sacral neural
crest failed to compensate for the loss of
ganglion cells in HD. In addition, their
development in the gut, if at all, appeared to be
grossly distorted with hypertrophied nerve
fibres ending blindly in the gut wall.42 Our
results showed that in HD patients, SOX10
expression in the distal colon was aVected;
there was a significant reduction in the level of
SOX10 expression in the aganglionic bowel
segment. Moderate levels of SOX10 expression
were detected in the abnormal nerve trunks
which occupy the space of the abnormal
ganglia. In the aganglionic bowel segments of
HD patients reduced SOX10 expression is
likely to be due to the absence of intrinsic gan-
glion cells, which are normally SOX10 positive,
in the aVected distal colon. The residual weak
SOX10 expression detected clearly came from
extrinsic nerves originated from sources other
than the vagal neural crest; the weak signals
could probably also come from the glial cell
population of the abnormal ganglia. We argue
that in HD patients, SOX10 expressed in the
aVected sacral region may have abnormal
interactions with neurotrophic factors38 43 44 or
with acetylcholine receptor which could be
transactivated by SOX10,45 and as a result
stimulate the growth of cholinergic and other
excitatory nerve fibres in the aganglionic
bowel.
For the non-syndromic HD patients exam-
ined in this study, none had mutations in the
coding region of the SOX10 gene except for
two patients who had silent and polymorphic
DNA changes in the SOX10 gene. These
patients probably harboured diVerent genetic
alterations. It is therefore important to note
that expression of the SOX10 gene was aVected
in all cases. This suggests that SOX10 may be a
key molecule in the functioning of the enteric
ganglia, and may be involved in diVerent regu-
latory pathways and signalling cascades for the
ENS. In the Dom mouse model, it was found
that expression of ENDRB was reduced in Dom
heterozygotes and was absent in Dom homo-
zygous mutants, suggesting that the signalling
pathway of EDN3 and its receptor ENDRB is
linked, either directly or indirectly, with the
activity of the transcription factor Sox10 in
mice.21 Mutations in the EDNRB and EDN3
genes have also been identified in
Waardenburg-Hirschsprung patients,7 8 10 11
suggesting a link between SOX10 and the
endothelin signalling pathways. Recently, by
cell transfection assays, it was demonstrated
that SOX10 together with PAX3 could activate
MITF and c-ret genes, which were crucial for
melanocyte and enteric neurone development,
respectively.46–50 Our SOX10 results would sup-
port the idea that the functions of SOX10 are
associated with many of the candidate genes for
HD and Waardenburg syndrome.
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